'McKesson and CD&R near $5B-plus deal to buy infusion services provider'- Financial Times
https://www.ft.com/content/0bc54eaf-d545-4591-bb7c-ec3cbc1cb89a
Share
Why It Matters
McKesson, a big medicine supplier, is buying an infusion company for over five billion dollars. When large companies buy smaller ones, watch if the buyer gets stronger or takes on too much risk.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.